Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually. Unfortunately, many cases are detected at advanced stages due to the lack ...

Background C-reactive protein (CRP) is commonly used to assess systemic inflammation, yet its prognostic value in acute ...

CGP identifies TP53 and SMAD4 mutations as negative prognostic markers, while PTEN mutations correlate with improved survival in CRC patients. Despite no significant survival advantage, CGP-guided ...

Sepsis is a common and serious complication in intensive care unit patients. An important factor in optimizing survival rates in septic patients is the ability to start treatment early in the course ...

Measuring copeptin levels in patients with hypotonic hyponatremia on emergency department (ED) admission provided key diagnostic insights. The copeptin to urinary sodium ratio more accurately ...

Prognostic impact of DDR mutations (mt) in IDH mutant high-grade gliomas (HGG). A phase 1, first-in-human study of regorafenib plus temozolomide with or without radiotherapy in patients with newly ...

Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate. Patients often relapse after receiving initial therapy, making it especially ...

Primary Site and Race on Survival Patterns in Esophageal Cancer: A NCDB Study In a retrospective cohort study, 522 primary HNSCC patients diagnosed between July 2010 and March 2023 were included.

Researchers at the State University of Campinas (UNICAMP) in São Paulo, Brazil, have identified a new biomarker that may help determine the prognosis for patients with gastric cancer, the fifth most ...